Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

A comparison between minimized extracorporeal circuits and conventional extracorporeal circuits in patients undergoing aortic valve surgery: is 'minimally invasive extracorporeal circulation' just low prime or closed loop perfusion ?

Starinieri P, Declercq PE, Robic B, Yilmaz A, Van Tornout M, Dubois J, Mees U, Hendrikx M.

Perfusion. 2017 Jul;32(5):403-408. doi: 10.1177/0267659117691814. Epub 2017 Feb 1.

PMID:
28553780
2.

Reduced cortisol metabolism during critical illness.

Boonen E, Vervenne H, Meersseman P, Andrew R, Mortier L, Declercq PE, Vanwijngaerden YM, Spriet I, Wouters PJ, Vander Perre S, Langouche L, Vanhorebeek I, Walker BR, Van den Berghe G.

N Engl J Med. 2013 Apr 18;368(16):1477-88. doi: 10.1056/NEJMoa1214969. Epub 2013 Mar 19.

3.

Neuronal migration depends on intact peroxisomal function in brain and in extraneuronal tissues.

Janssen A, Gressens P, Grabenbauer M, Baumgart E, Schad A, Vanhorebeek I, Brouwers A, Declercq PE, Fahimi D, Evrard P, Schoonjans L, Collen D, Carmeliet P, Mannaerts G, Van Veldhoven P, Baes M.

J Neurosci. 2003 Oct 29;23(30):9732-41.

4.

D,L-3-hydroxybutyrate treatment of multiple acyl-CoA dehydrogenase deficiency (MADD).

Van Hove JL, Grünewald S, Jaeken J, Demaerel P, Declercq PE, Bourdoux P, Niezen-Koning K, Deanfeld JE, Leonard JV.

Lancet. 2003 Apr 26;361(9367):1433-5.

PMID:
12727399
5.

The neuronal migration defect in mice with Zellweger syndrome (Pex5 knockout) is not caused by the inactivity of peroxisomal beta-oxidation.

Baes M, Gressens P, Huyghe S, De NK, Qi C, Jia Y, Mannaerts GP, Evrard P, Van VP, Declercq PE, Reddy JK.

J Neuropathol Exp Neurol. 2002 Apr;61(4):368-74.

PMID:
11939592
6.

Mitochondrial alterations caused by defective peroxisomal biogenesis in a mouse model for Zellweger syndrome (PEX5 knockout mouse).

Baumgart E, Vanhorebeek I, Grabenbauer M, Borgers M, Declercq PE, Fahimi HD, Baes M.

Am J Pathol. 2001 Oct;159(4):1477-94.

7.

Isoprenoid biosynthesis is not compromised in a Zellweger syndrome mouse model.

Vanhorebeek I, Baes M, Declercq PE.

Biochim Biophys Acta. 2001 May 31;1532(1-2):28-36.

PMID:
11420171
8.

Oxidative catabolism of alpha-tocopherol in rat liver microsomes.

Van Houte H, De Hoffmann E, Van Veldhoven PP, Mannaerts GP, Carchon H, Baes MI, Declercq PE.

Lipids. 2001 Apr;36(4):367-72.

PMID:
11383687
9.

Prenatal and postnatal development of peroxisomal lipid-metabolizing pathways in the mouse.

Huyghe S, Casteels M, Janssen A, Meulders L, Mannaerts GP, Declercq PE, Van Veldhoven PP, Baes M.

Biochem J. 2001 Feb 1;353(Pt 3):673-80.

10.
11.

Channelling of intermediates in the biosynthesis of phosphatidylcholine and phosphatidylethanolamine in mammalian cells.

Bladergroen BA, Geelen MJ, Reddy AC, Declercq PE, Van Golde LM.

Biochem J. 1998 Sep 15;334 ( Pt 3):511-7.

12.

Gel-shift analysis and identification of RXREs and RAREs by PCR-based selection.

Baes MI, Declercq PE.

Methods Mol Biol. 1998;89:377-88. Review. No abstract available.

PMID:
9664340
13.

Effects of 2',3'-dideoxycytidine and 2',3'-dideoxycytidine 5'-triphosphate on phospholipid metabolism in permeabilized rat hepatocytes.

De Groote K, Naesens L, Balzarini J, Baes MI, Declercq PE.

Biochem Pharmacol. 1997 Sep 15;54(6):713-9.

PMID:
9310348
14.

A mouse model for Zellweger syndrome.

Baes M, Gressens P, Baumgart E, Carmeliet P, Casteels M, Fransen M, Evrard P, Fahimi D, Declercq PE, Collen D, van Veldhoven PP, Mannaerts GP.

Nat Genet. 1997 Sep;17(1):49-57.

PMID:
9288097
15.

Metabolism of dolichol, dolichoic acid and nordolichoic acid in cultured cells.

Van Houte HA, Van Veldhoven PP, Mannaerts GP, Baes MI, Declercq PE.

Biochim Biophys Acta. 1997 Jul 12;1347(1):93-100.

PMID:
9233691
16.

Swelling-activated efflux of taurine and other organic osmolytes in endothelial cells.

Manolopoulos VG, Voets T, Declercq PE, Droogmans G, Nilius B.

Am J Physiol. 1997 Jul;273(1 Pt 1):C214-22.

PMID:
9252459
17.

DNA binding preferences of PPAR alpha/RXR alpha heterodimers.

Castelein H, Declercq PE, Baes M.

Biochem Biophys Res Commun. 1997 Apr 7;233(1):91-5.

PMID:
9144402
18.

Palmitoyl-CoA synthetase on the external surface of isolated rat hepatocytes.

de Groote K, Velghe G, Stals HK, Baes MI, Declercq PE.

Cell Biochem Funct. 1996 Dec;14(4):277-81.

PMID:
8952046
19.

Sequence requirements for high affinity retinoid X receptor-alpha homodimer binding.

Castelein H, Janssen A, Declercq PE, Baes M.

Mol Cell Endocrinol. 1996 May 17;119(1):11-20.

PMID:
8793849
20.

Volume regulation in rat brain glial cells: lack of a substantial contribution of free amino acids.

Mountian I, Declercq PE, Van Driessche W.

Am J Physiol. 1996 May;270(5 Pt 1):C1319-25.

PMID:
8967431
21.

Antagonism of COUP-TF and PPAR alpha/RXR alpha on the activation of the malic enzyme gene promoter: modulation by 9-cis RA.

Baes M, Castelein H, Desmet L, Declercq PE.

Biochem Biophys Res Commun. 1995 Oct 4;215(1):338-45.

PMID:
7575611
22.

Regulatory volume decrease in cultured kidney cells (A6): role of amino acids.

De Smet P, Simaels J, Declercq PE, Van Driessche W.

J Gen Physiol. 1995 Sep;106(3):525-42.

23.

Bacterial metabolism shown by magnetic resonance spectroscopy.

Demaerel P, Van Hecke P, Van Oostende S, Baert AL, Jaeken J, Declercq PE, Eggermont E, Plets C.

Lancet. 1994 Oct 29;344(8931):1234-5. No abstract available.

PMID:
7934568
24.

The peroxisome proliferator activated receptor regulates malic enzyme gene expression.

Castelein H, Gulick T, Declercq PE, Mannaerts GP, Moore DD, Baes MI.

J Biol Chem. 1994 Oct 28;269(43):26754-8.

26.

Peroxisome proliferators and T3 operate by way of distinct receptors.

Castelein H, Declercq PE, Mannaerts GP, Baes MI.

FEBS Lett. 1993 Oct 11;332(1-2):24-6.

27.

Factors influencing triacylglycerol synthesis in permeabilized rat hepatocytes.

Stals HK, Mannaerts GP, Declercq PE.

Biochem J. 1992 May 1;283 ( Pt 3):719-25.

28.
29.

Simplified assay of Acyl-CoA:dihydroxyacetone-phosphate acyltransferase.

Stals HK, Declercq PE.

Clin Chem. 1992 Apr;38(4):610-1. No abstract available.

30.
31.

Simplified assay of galactose-1-phosphate uridyltransferase.

Lagrou K, Declercq PE.

Clin Chem. 1991 Dec;37(12):2157-8. No abstract available.

PMID:
1764807
32.

Characterization of the mitochondrial carnitine palmitoyltransferase enzyme system. I. Use of inhibitors.

Declercq PE, Falck JR, Kuwajima M, Tyminski H, Foster DW, McGarry JD.

J Biol Chem. 1987 Jul 15;262(20):9812-21.

33.

Interaction of malonyl-CoA and 2-tetradecylglycidyl-CoA with mitochondrial carnitine palmitoyltransferase I.

Declercq PE, Venincasa MD, Mills SE, Foster DW, McGarry JD.

J Biol Chem. 1985 Oct 15;260(23):12516-22.

34.

Rat liver dihydroxyacetone-phosphate acyltransferases and their contribution to glycerolipid synthesis.

Declercq PE, Haagsman HP, Van Veldhoven P, Debeer LJ, Van Golde LM, Mannaerts GP.

J Biol Chem. 1984 Jul 25;259(14):9064-75.

35.

Effects of benfluorex and fenofibrate treatment on mitochondrial and peroxisomal marker enzymes in rat liver.

Van Veldhoven P, Declercq PE, Debeer LJ, Mannaerts GP.

Biochem Pharmacol. 1984 Apr 1;33(7):1153-5.

PMID:
6712725
36.
37.
38.

Glycerol-3-phosphate content and triacylglycerol synthesis in isolated hepatocytes from fed and starved rats.

Debeer LJ, Declercq PE, Mannaerts GP.

FEBS Lett. 1981 Feb 9;124(1):31-4. No abstract available.

Supplemental Content

Loading ...
Support Center